Lazertinib
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for Lazertinib, covering 2021-12-22 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer [Phase 1]